DexCom Announces Upcoming Presentations

Before you go, we thought you'd like these...
Before you go close icon

DexCom Announces Upcoming Presentations

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NAS: DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:

  • Kevin Sayer, President & Chief Operating Officer, will present an update on DexCom at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas, Nevada on Thursday, May 16, 2013 10:00 a.m. (PDT). The presentation, which will occur live at the Encore Hotel, will be concurrently webcast.
  • Steve Pacelli, EVP, Strategy and Corporate Development, will present an update on DexCom at the 38th Annual dbAccess Health Care Conference in Boston, Massachusetts on Wednesday, May 29, at 12:00 p.m. (EDT). The presentation, which will occur live at the Westin Boston Waterfront Hotel, will be concurrently webcast.

The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to "About", then "Investor Relations", and then "Events and Webcasts", and the presentations will be archived there for future reference.


About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

Cautionary Statement Regarding Forward Looking Statements
DexCom is a medical device company with a limited operating history. Successful commercialization of the company's products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company's development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company's quarterly report on Form 10-Q for the quarter ended March 31, 2013, as filed with the Securities and Exchange Commission on May 1, 2013.



DexCom, Inc.
Steven R. Pacelli
Executive Vice President, Strategy and Corporate Development
858-200-0200

KEYWORDS:   United States  North America  California  Massachusetts  Nevada

INDUSTRY KEYWORDS:

The article DexCom Announces Upcoming Presentations originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners